Literature DB >> 24014312

Bioreactor cultivation of anatomically shaped human bone grafts.

Joshua P Temple1, Keith Yeager, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, Warren L Grayson.   

Abstract

In this chapter, we describe a method for engineering bone grafts in vitro with the specific geometry of the temporomandibular joint (TMJ) condyle. The anatomical geometry of the bone grafts was segmented from computed tomography (CT) scans, converted to G-code, and used to machine decellularized trabecular bone scaffolds into the identical shape of the condyle. These scaffolds were seeded with human bone marrow-derived mesenchymal stem cells (MSCs) using spinner flasks and cultivated for up to 5 weeks in vitro using a custom-designed perfusion bioreactor system. The flow patterns through the complex geometry were modeled using the FloWorks module of SolidWorks to optimize bioreactor design. The perfused scaffolds exhibited significantly higher cellular content, better matrix production, and increased bone mineral deposition relative to non-perfused (static) controls after 5 weeks of in vitro cultivation. This technology is broadly applicable for creating patient-specific bone grafts of varying shapes and sizes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24014312      PMCID: PMC4476534          DOI: 10.1007/7651_2013_33

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces.

Authors:  Vassilios I Sikavitsas; Gregory N Bancroft; Heidi L Holtorf; John A Jansen; Antonios G Mikos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

2.  Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner.

Authors:  Gregory N Bancroft; Vassilios I Sikavitsas; Juliette van den Dolder; Tiffany L Sheffield; Catherine G Ambrose; John A Jansen; Antonios G Mikos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

3.  Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds.

Authors:  S L Ishaug; G M Crane; M J Miller; A W Yasko; M J Yaszemski; A G Mikos
Journal:  J Biomed Mater Res       Date:  1997-07

4.  Optimizing the medium perfusion rate in bone tissue engineering bioreactors.

Authors:  Warren L Grayson; Darja Marolt; Sarindr Bhumiratana; Mirjam Fröhlich; X Edward Guo; Gordana Vunjak-Novakovic
Journal:  Biotechnol Bioeng       Date:  2010-12-22       Impact factor: 4.530

5.  Nucleation and growth of mineralized bone matrix on silk-hydroxyapatite composite scaffolds.

Authors:  Sarindr Bhumiratana; Warren L Grayson; Andrea Castaneda; Danielle N Rockwood; Eun S Gil; David L Kaplan; Gordana Vunjak-Novakovic
Journal:  Biomaterials       Date:  2011-01-22       Impact factor: 12.479

6.  Ingrowth of human mesenchymal stem cells into porous silk particle reinforced silk composite scaffolds: An in vitro study.

Authors:  Danielle N Rockwood; Eun Seok Gil; Sang-Hyug Park; Jonathan A Kluge; Warren Grayson; Sarindr Bhumiratana; Rangam Rajkhowa; Xungai Wang; Sung Jun Kim; Gordana Vunjak-Novakovic; David L Kaplan
Journal:  Acta Biomater       Date:  2010-07-23       Impact factor: 8.947

7.  Engineering anatomically shaped human bone grafts.

Authors:  Warren L Grayson; Mirjam Fröhlich; Keith Yeager; Sarindr Bhumiratana; M Ete Chan; Christopher Cannizzaro; Leo Q Wan; X Sherry Liu; X Edward Guo; Gordana Vunjak-Novakovic
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-09       Impact factor: 11.205

8.  Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture.

Authors:  Mirjam Fröhlich; Warren L Grayson; Darja Marolt; Jeffrey M Gimble; Nevenka Kregar-Velikonja; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part A       Date:  2010-01       Impact factor: 3.845

9.  Engineering bone tissue from human embryonic stem cells.

Authors:  Darja Marolt; Iván Marcos Campos; Sarindr Bhumiratana; Ana Koren; Petros Petridis; Geping Zhang; Patrice F Spitalnik; Warren L Grayson; Gordana Vunjak-Novakovic
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

  9 in total
  7 in total

Review 1.  The potential impact of bone tissue engineering in the clinic.

Authors:  Ruchi Mishra; Tyler Bishop; Ian L Valerio; John P Fisher; David Dean
Journal:  Regen Med       Date:  2016-08-23       Impact factor: 3.806

Review 2.  Challenges in engineering osteochondral tissue grafts with hierarchical structures.

Authors:  Ivana Gadjanski; Gordana Vunjak-Novakovic
Journal:  Expert Opin Biol Ther       Date:  2015-07-20       Impact factor: 4.388

Review 3.  Manufacturing artificial bone allografts: a perspective.

Authors:  Emma Steijvers; Armaan Ghei; Zhidao Xia
Journal:  Biomater Transl       Date:  2022-03-28

Review 4.  Three-dimensional osteogenic and chondrogenic systems to model osteochondral physiology and degenerative joint diseases.

Authors:  Peter G Alexander; Riccardo Gottardi; Hang Lin; Thomas P Lozito; Rocky S Tuan
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-03

Review 5.  Bone Marrow Stromal Stem Cells in Tissue Engineering and Regenerative Medicine.

Authors:  A Polymeri; W V Giannobile; D Kaigler
Journal:  Horm Metab Res       Date:  2016-11-21       Impact factor: 2.788

6.  Fabrication of Decellularized Engineered Extracellular Matrix through Bioreactor-Based Environment for Bone Tissue Engineering.

Authors:  Hanieh Nokhbatolfoghahaei; Zahrasadat Paknejad; Mahboubeh Bohlouli; Maryam Rezai Rad; Pouyan Aminishakib; Samira Derakhshan; Leila Mohammadi Amirabad; Nasser Nadjmi; Arash Khojasteh
Journal:  ACS Omega       Date:  2020-12-02

7.  Regenerative Potential of Mandibular Condyle Cartilage and Bone Cells Compared to Costal Cartilage Cells When Seeded in Novel Gelatin Based Hydrogels.

Authors:  A R Chin; J M Taboas; A J Almarza
Journal:  Ann Biomed Eng       Date:  2020-11-05       Impact factor: 3.934

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.